Carnegie Capital Asset Management LLC held its position in Equifax, Inc. (NYSE:EFX) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,225 shares of the credit services provider’s stock at the close of the second quarter. Carnegie Capital Asset Management LLC’s holdings in Equifax were worth $324,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. IFP Advisors Inc increased its holdings in shares of Equifax by 24.6% in the 2nd quarter. IFP Advisors Inc now owns 928 shares of the credit services provider’s stock valued at $128,000 after acquiring an additional 183 shares during the last quarter. SNS Financial Group LLC purchased a new position in shares of Equifax in the 2nd quarter valued at about $200,000. Park Avenue Securities LLC purchased a new position in shares of Equifax in the 2nd quarter valued at about $201,000. Wilbanks Smith & Thomas Asset Management LLC purchased a new position in shares of Equifax in the 1st quarter valued at about $202,000. Finally, Captrust Financial Advisors purchased a new position in shares of Equifax in the 2nd quarter valued at about $204,000. Institutional investors and hedge funds own 90.00% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Equifax, Inc. (EFX) Holdings Maintained by Carnegie Capital Asset Management LLC” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.watchlistnews.com/equifax-inc-efx-holdings-maintained-by-carnegie-capital-asset-management-llc/1601206.html.

Shares of Equifax, Inc. (NYSE:EFX) opened at 105.99 on Friday. The firm has a market capitalization of $12.76 billion, a PE ratio of 22.45 and a beta of 0.93. The firm’s 50-day moving average price is $133.48 and its 200-day moving average price is $136.54. Equifax, Inc. has a 52-week low of $89.59 and a 52-week high of $147.02.

Equifax (NYSE:EFX) last announced its quarterly earnings data on Wednesday, July 26th. The credit services provider reported $1.60 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.57 by $0.03. The firm had revenue of $856.70 million during the quarter, compared to analyst estimates of $860.48 million. Equifax had a return on equity of 24.88% and a net margin of 17.44%. Equifax’s quarterly revenue was up 5.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.43 earnings per share. On average, equities analysts predict that Equifax, Inc. will post $5.98 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 15th. Investors of record on Friday, August 25th were issued a $0.39 dividend. This represents a $1.56 annualized dividend and a yield of 1.47%. The ex-dividend date of this dividend was Wednesday, August 23rd. Equifax’s dividend payout ratio is currently 33.05%.

EFX has been the subject of a number of research analyst reports. Stifel Nicolaus reissued a “buy” rating and issued a $149.00 target price on shares of Equifax in a research report on Tuesday, September 26th. Wells Fargo & Company raised Equifax from a “market perform” rating to an “outperform” rating and decreased their target price for the company from $135.00 to $127.00 in a research report on Friday, September 22nd. SunTrust Banks, Inc. upped their target price on Equifax from $110.00 to $155.00 in a research report on Friday, September 15th. Stephens reissued a “hold” rating and issued a $110.00 target price (down from $145.00) on shares of Equifax in a research report on Thursday, September 14th. Finally, J P Morgan Chase & Co reissued a “buy” rating on shares of Equifax in a research report on Friday, September 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $130.50.

In other news, insider Rodolfo O. Ploder sold 1,719 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $145.70, for a total transaction of $250,458.30. Following the completion of the transaction, the insider now directly owns 43,648 shares of the company’s stock, valued at $6,359,513.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO John W. Gamble, Jr. sold 6,500 shares of the company’s stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $145.60, for a total value of $946,400.00. Following the transaction, the chief financial officer now directly owns 42,078 shares of the company’s stock, valued at $6,126,556.80. The disclosure for this sale can be found here. Over the last three months, insiders sold 12,219 shares of company stock valued at $1,780,938. 1.29% of the stock is owned by corporate insiders.

Equifax Company Profile

Equifax Inc is a global provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The Company operates in four segments: U.S. Information Solutions (USIS), International, Workforce Solutions and Global Consumer Solutions. Its products and services are based on databases of consumer and business information derived from various sources, including credit, financial assets, telecommunications and utility payments, employment, income, demographic and marketing data.

Institutional Ownership by Quarter for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.